Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial. - Wikidata - wikimedia - TriplyDB

Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial.

Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial.

http://www.wikidata.org/entity/Q36809473

about

Increased Risk of Group B Streptococcus Invasive Infection in HIV-Exposed but Uninfected Infants: A Review of the Evidence and Possible Mechanisms Transfer of Maternal Antimicrobial Immunity to HIV-Exposed Uninfected Newborns Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries Challenges in reducing group B Streptococcus disease in African settings.Temporal Changes in Invasive Group B Streptococcus Serotypes: Implications for Vaccine Development Maternal colonization with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal Kenya.Opsonophagocytic Antibodies to Serotype Ia, Ib, and III Group B Streptococcus among Korean Infants and in Intravenous Immunoglobulin Products.Serotype Distribution, Population Structure, and Antimicrobial Resistance of Group B Streptococcus Strains Recovered from Colonized Pregnant Women.Strategies to develop vaccines of pediatric interest.Screening for early-onset invasive group B Streptococcal disease in neonates in an Irish hospital (2001-2014): a retrospective audit.Vaccination of HIV-infected pregnant women: implications for protection of their young infants.Neonatal protection and preterm birth reduction following maternal group B streptococcus vaccination in a mouse model.Role of HIV exposure and infection in relation to neonatal GBS disease and rectovaginal GBS carriage: a systematic review and meta-analysis.Association between antibodies against group B Streptococcus surface proteins and recto-vaginal colonisation during pregnancy.Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children.Invasive bacterial disease trends and characterization of group B streptococcal isolates among young infants in southern Mozambique, 2001-2015.Factors influencing access of pregnant women and their infants to their local healthcare system: a prospective, multi-centre, observational study.Protective effect of Group B Streptococcus type-III polysaccharide conjugates against maternal colonization, ascending infection and neonatal transmission in rodent models.Group B Streptococcal Colonization, Molecular Characteristics, and Epidemiology.Maternal immunisation: What have been the gains? Where are the gaps? What does the future hold?

P2860

Q28067423-5359C0D7-A89C-454C-B50A-A3B7006AFE1D Q28070259-C8B7E307-6711-47A5-80B2-C7EA727ECF21 Q28075884-E4111B36-CCEC-420A-9CF3-46A492E0BC85 Q30241490-5FABCB45-4279-416E-8AE9-E8A41211718B Q36236399-D8B5DBAB-C27B-4A94-97B5-C2F88A737D10 Q37074413-0426B840-B34D-4EF1-9E51-A2D4B1F4998E Q37740442-DC523D46-6C32-477A-95DB-87EE0D3AB20E Q38794756-99E5DC60-C2F1-4D62-876F-50A97BF66185 Q38819027-CCB5E4EE-C077-461A-BB93-2BD484B79630 Q38918659-B498D8DC-28CE-4CFF-A7B5-B418BC136E98 Q40051928-693713C7-9727-4769-9828-6D835CF43D22 Q40410171-CF952EFD-35F3-43FB-8C31-59893C339C04 Q45397507-7629EEEF-BA9F-4FF9-9ECA-441B326DC2CB Q46470356-9EADE48A-AE99-4F79-A22C-35F88B61ED23 Q46954965-93F31CDB-FCCC-41CB-B84C-BFD052D7013B Q47546256-F0EC6BA8-B265-49A4-9432-298AEB94891C Q47656751-5003A376-3C16-4386-9DAF-B5C4DC4D45B2 Q50129993-5F1E0110-D20A-4487-AFBB-7DF9D5D52C31 Q52624533-BBA9DD9B-7228-474F-A835-9BD49EAB7ECB Q59133818-633A04A3-9643-45B2-9A91-C451C5FB7D59

P2860

Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial.

http://www.wikidata.org/entity/Q36809473

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Group B streptococcus vaccinat ...... open-label, multicentre trial.

@ast

Group B streptococcus vaccinat ...... open-label, multicentre trial.

@en

type

label

Group B streptococcus vaccinat ...... open-label, multicentre trial.

@ast

Group B streptococcus vaccinat ...... open-label, multicentre trial.

@en

prefLabel

Group B streptococcus vaccinat ...... open-label, multicentre trial.

@ast

Group B streptococcus vaccinat ...... open-label, multicentre trial.

@en

P1433

Q36809473-7252ABB0-BB1A-4D57-8217-1ED4692548B0

P1476

Q36809473-385A9C59-B5CF-41C0-80BF-2C93787B08F0

P2093

Q36809473-38CD01C3-78D5-4080-9526-A348D782E775

Q36809473-4128DF1A-3B22-4A66-928F-122A7E24081F

Q36809473-4F36C8FB-9175-4C97-9C72-F7E85F47272E

Q36809473-70DC1827-6DD6-433E-BF23-78FDC990FBB8

Q36809473-C7C4E065-2013-4441-AFC5-8D73BDFABCEA

Q36809473-D3709CBF-D8FC-4C52-A323-EDE9E5365648

Q36809473-E24E2349-96D5-4681-834D-5FAFD3159F50

Q36809473-F338DFA7-A769-4A70-B9CC-03718BD6D8C0

P2860

Q36809473-0E300A4A-D951-41FA-9D3D-C1F6394F8B13

Q36809473-13C9333A-CD42-4403-AA68-271EB2B3A149

Q36809473-17003B49-0DDE-4BC1-87DE-025FE0C7E932

Q36809473-218B2F41-3DC2-4308-B49E-66E254A74392

Q36809473-24485EAC-99C3-4B0F-85E3-43F3C7F1501D

Q36809473-2F8ED70A-1194-4743-99D0-67EB2F579C68

Q36809473-340DD6B9-33B7-4393-9851-7B5291E459CD

Q36809473-477C0E74-FB3B-4BD4-8599-3275A6FDA3BD

Q36809473-50A8A72F-AE74-43EA-AA9A-9E413F6EA364

Q36809473-604559AB-81D8-4726-A7E6-3CAC3BDFF7A4

P304

Q36809473-AB485360-46A0-4A44-917F-42BEF7FDC47C

P31

Q36809473-FC40B9EE-366E-4104-BB75-083573B2507F

P356

Q36809473-2E7EB281-48F0-4F2F-9867-9B18B0E2FC87

P433

Q36809473-AFD7363F-C8D2-4FCB-A900-2C00B6D99D77

P478

Q36809473-744C3EFB-AC55-4DD4-8C87-1338B75D6637

P50

Q36809473-325ED165-71D2-4EE4-A8E1-8A0C7400230E

Q36809473-49D33AD2-FA05-4C02-96CC-F63105B82A51

Q36809473-4E974D70-55AD-4FF1-96CC-8780EA38B8F5

Q36809473-D3DA4E3A-9D04-4425-B6D6-A814ABACEA64

Q36809473-EFEFC509-24E7-4355-B6B0-B62286FF306B

P577

Q36809473-A3664BBD-3D55-40F7-BC9D-A9F308516740

P698

Q36809473-41B15F74-0612-4649-B4B8-5F153AAE2FAB

P921

Q36809473-A49EFE5F-ADF8-4B9D-8FA3-16222B5C20CD

Q36809473-C901E118-057E-45D9-BB52-08C02BF51197

P932

Q36809473-FB792ECB-E672-43AD-80A6-35AA77BFB225

P356

S1473-3099(15)00484-3

P1433

The Lancet Infectious Diseases

P1476

Group B streptococcus vaccinat ...... open-label, multicentre trial.

@en

P2093

Anthonet Koen

http://www.w3.org/2001/XMLSchema#string

Doris Kayambo

http://www.w3.org/2001/XMLSchema#string

Frederik Wittke

http://www.w3.org/2001/XMLSchema#string

Karen Slobod

http://www.w3.org/2001/XMLSchema#string

Lisa Jose

http://www.w3.org/2001/XMLSchema#string

Morounfolu Olugbosi

http://www.w3.org/2001/XMLSchema#string

Peter M Dull

http://www.w3.org/2001/XMLSchema#string

Robert Mboizi

http://www.w3.org/2001/XMLSchema#string

P2860

Assessment of trends in biological and behavioural surveillance data: is there any evidence of declining HIV prevalence or incidence in Malawi?

Placental and breast transfer of antibodies after maternal immunization with polysaccharide meningococcal vaccine: a randomized, controlled evaluation.

Recent HIV prevalence trends among pregnant women and all women in sub-Saharan Africa: implications for HIV estimates.

Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads.

Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues

Maternal immunization with Haemophilus influenzae type b vaccines in different populations.

Increased risk for group B Streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004-2008(1).

Burden of invasive group B Streptococcus disease and early neurological sequelae in South African infants.

Group B Streptococcus and HIV infection in pregnant women, Malawi, 2008-2010

Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial.

P304

546-555

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1473-3099(15)00484-3

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Shabir A. Madhi

Clare L. Cutland

Robert Heyderman

P577

2016-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26869376

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

multicenter trial

P932

4835545

http://www.w3.org/2001/XMLSchema#string